COMMUNIQUÉ DE PRESSE publié le 24/05/2023 à 12:00, il y a 3 années 1 mois Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
COMMUNIQUÉ DE PRESSE publié le 27/04/2023 à 12:00, il y a 3 années 1 mois Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
COMMUNIQUÉ DE PRESSE publié le 12/04/2023 à 22:00, il y a 3 années 2 mois Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 12:00, il y a 3 années 2 mois Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
COMMUNIQUÉ DE PRESSE publié le 05/01/2023 à 13:00, il y a 3 années 5 mois Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy
COMMUNIQUÉ DE PRESSE publié le 03/01/2023 à 13:00, il y a 3 années 5 mois Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)
Publié le 26/06/2026 à 23:00, il y a 1 heure Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 1 heure 10 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 1 heure 45 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 26/06/2026 à 14:05, il y a 9 heures 55 minutes SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Publié le 26/06/2026 à 23:36, il y a 24 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 24 minutes EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 32 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Publié le 26/06/2026 à 19:50, il y a 4 heures 9 minutes Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live
